An interventional study of Mindfulness-Based Cognitive Behavioral Mobile Intervention in Misophonia and Misophonia Treatment, sponsored by Sakarya University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-25.
Sponsored by Sakarya University · Not applicable, Interventional, and Treatment
Misophonia is characterized by strong emotional and physiological reactions to specific trigger sounds and may interfere with daily functioning and emotional well-being. This randomized controlled trial will evaluate the effectiveness of a mobile application based on mindfulness-based cognitive behavioral interventions for adults with misophonia symptoms.
A total of 60 participants will be randomly assigned to either an intervention group or a control group. Participants in the intervention group will use a three-week mobile intervention that includes psychoeducation, cognitive behavioral techniques, gradual exposure to trigger sounds, mindfulness, breathing and relaxation exercises, and self-monitoring tools. The control group will not receive the mobile intervention during the study period.
Outcomes will be assessed before the intervention, immediately after the three-week intervention, and four weeks after the intervention. The main outcome will be change in misophonia symptoms. Secondary outcomes will include depression, anxiety, stress, and difficulties in emotion regulation.
This study is a randomized controlled trial designed to evaluate the effectiveness of a mobile application based on mindfulness-based cognitive behavioral interventions for individuals with misophonia symptoms.
The mobile intervention was developed to address cognitive, emotional, behavioral, and physiological processes associated with misophonia. The intervention integrates psychoeducation, cognitive behavioral therapy, mindfulness-based strategies, gradual exposure and desensitization, breathing and relaxation exercises, and self-monitoring. The intervention specifically targets threat appraisal, automatic thoughts, avoidance behaviors, physiological arousal, and difficulties in emotion regulation.
A total of 60 eligible participants will be randomly assigned to an intervention group or a control group using stratified block randomization. The intervention group will receive access to the mobile application for three weeks. The application includes educational content about misophonia, identification of individual trigger sounds, cognitive restructuring exercises, a thought diary, graded exposure to trigger sounds, Subjective Units of Distress Scale (SUDS) monitoring, breathing exercises, mindfulness practices, relaxation tools, and supportive audio content. The exposure component includes graded exposure, distress monitoring, breathing support, and a safe-stop option.
Participants will be evaluated at three time points: baseline before the intervention, immediately after completion of the three-week intervention, and four weeks after the intervention. The primary outcome will be change in misophonia symptoms. Secondary outcomes will include depression, anxiety, stress, and difficulties in emotion regulation. These outcomes will be assessed using the Misophonia Scale, the Depression Anxiety Stress Scale-21 (DASS-21), and the 16-item Difficulties in Emotion Regulation Scale.
The study will examine whether the mobile intervention produces improvements in misophonia symptoms and related psychological outcomes compared with the control condition.
545 studies on the registry are indexed under Emotional Regulation; 188 are open to participants now.
This study's planned enrollment of 60 is below the median of 79 across 498 interventional studies indexed under Emotional Regulation.
Browse Emotional Regulation studies →Sakarya University is the lead sponsor of 190 studies on the registry; 53 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants assigned to this arm will use the mindfulness-based cognitive behavioral mobile application for three weeks. The intervention includes psychoeducation, cognitive restructuring, graded exposure to trigger sounds, mindfulness practices, breathing and relaxation exercises, and self-monitoring tools.
Behavioral: Mindfulness-Based Cognitive Behavioral Mobile Intervention
Participants assigned to this arm will not receive the mobile intervention during the study period. They will complete the same outcome assessments as the intervention group at baseline, post-intervention, and follow-up.
A three-week mobile behavioral intervention developed for adults with misophonia symptoms. The intervention integrates psychoeducation, cognitive behavioral techniques, self-monitoring, cognitive restructuring, graded exposure to trigger sounds, Subjective Units of Distress Scale (SUDS) monitoring, mindfulness practices, breathing exercises, relaxation techniques, and supportive audio content. The program is designed to target maladaptive thoughts, avoidance behaviors, emotional reactivity, physiological arousal, and difficulties in emotion regulation associated with misophonia.
Change in Misophonia Scale Total Score
Misophonia symptoms will be assessed using the 30-item Misophonia Scale developed by Koroglu and Durat (2024). Each item is rated on a 5-point Likert scale, yielding a total score ranging from 30 to 150. Higher scores indicate lower misophonia severity, whereas lower scores indicate greater misophonia severity. Changes in total scores will be compared between the intervention and control groups.
Time frame: Baseline, 3 weeks, and 7 weeks
Change in DASS-21 Depression Subscale Score
Depressive symptoms will be assessed using the Depression subscale of the 21-item Depression Anxiety Stress Scale (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale from 0 to 3. Higher scores indicate greater severity of depressive symptoms. Changes in depression scores will be compared between the intervention and control groups.
Time frame: Baseline, 3 weeks, and 7 weeks
Change in DASS-21 Anxiety Subscale Score
Anxiety symptoms will be assessed using the Anxiety subscale of the 21-item Depression Anxiety Stress Scale (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale from 0 to 3. Higher scores indicate greater severity of anxiety symptoms. Changes in anxiety scores will be compared between the intervention and control groups.
Time frame: Baseline, 3 weeks, and 7 weeks
Change in DASS-21 Stress Subscale Score
Stress symptoms will be assessed using the Stress subscale of the 21-item Depression Anxiety Stress Scale (DASS-21). The subscale consists of 7 items rated on a 4-point Likert scale from 0 to 3. Higher scores indicate greater severity of stress symptoms. Changes in stress scores will be compared between the intervention and control groups.
Time frame: Baseline, 3 weeks, and 7 weeks
Change in Difficulties in Emotion Regulation Scale-16 (DERS-16) Total Score
Difficulties in emotion regulation will be assessed using the 16-item Difficulties in Emotion Regulation Scale (DERS-16). The scale consists of 16 items rated on a 5-point Likert scale. Higher total scores indicate greater difficulties in emotion regulation. Changes in DERS-16 total scores will be compared between the intervention and control groups.
Time frame: Baseline, 3 weeks, and 7 weeks
Plan to share: No
No publications or documents are linked to this record.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.